Beth Y. Karlan, MD
Director, Women's Cancer Research Institute, Samuel Oschin Comprehensive Cancer Institute
Director, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology
Director, Gilda Radner Hereditary Cancer Detection Program
Gynecologic Oncologist
Beth Y. Karlan, MD is Director of the Women's Cancer Research Institute, the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology and the Gilda Radner Hereditary Cancer Detection Program. Dr. Karlan is also Professor of Obstetrics and Gynecology at the Geffen School of Medicine at the University of California, Los Angeles (UCLA).
Board certified in obstetrics and gynecology and in gynecologic oncology, Dr. Karlan has been awarded research grants from such groups as the Department of Defense, National Institutes of Health and the American Cancer Society. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility.
Dr. Karlan has written over 100 articles, many published in peer-reviewed publications, such as Gynecologic Oncology, Cancer, Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research. She also serves as an Editorial Board Member for Obstetrics and Gynecology, Journal of Clinical Oncology and Gynecologic Oncology. Dr. Karlan's national leadership is exemplified by her positions as President of the Society of Gynecologic Oncologists (2005-2006), a member of the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology and service on the Board of Governors of the American College of Surgeons. In 2006, Dr. Karlan was awarded the American Cancer Society, California Division, Early Detection Professorship. After a nationwide search, Dr. Karlan was appointed Editor-in-Chief for the Gynecologic Oncology Journal, effective January 2008.
Dr. Karlan is a magna cum laude graduate of Harvard-Radcliffe College. She received her medical degree from Harvard Medical School and the Harvard-Massachusetts Institute of Technology Program in Health Sciences and Technology. After finishing her residency at Yale-New Haven Hospital, Dr. Karlan completed a postdoctoral research fellowship in molecular biology at Yale University School of Medicine, and a clinical fellowship in gynecologic oncology at UCLA School of Medicine.
